Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia.

about

Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q41316658

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinico-biological significanc ...... ion in acute myeloid leukemia.

@en

type

Item

label

Clinico-biological significanc ...... ion in acute myeloid leukemia.

@en

prefLabel

Clinico-biological significanc ...... ion in acute myeloid leukemia.

@en

P1476

Clinico-biological significanc ...... sion in acute myeloid leukemia

@en

P2093

C-C Lin

http://www.w3.org/2001/XMLSchema#string

C-Y Liu

http://www.w3.org/2001/XMLSchema#string

H-A Hou

http://www.w3.org/2001/XMLSchema#string

H-F Tien

http://www.w3.org/2001/XMLSchema#string

J-L Tang

http://www.w3.org/2001/XMLSchema#string

J-W Lu

http://www.w3.org/2001/XMLSchema#string

L-I Lin

http://www.w3.org/2001/XMLSchema#string

M-H Tseng

http://www.w3.org/2001/XMLSchema#string

T-Y Lin

http://www.w3.org/2001/XMLSchema#string

W-C Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.

Analysis of thrombocyte development in CD41-GFP transgenic zebrafish.

Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

Zebrafish as a Model for the Study of Human Myeloid Malignancies

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.

SOCS, Inflammation, and Autoimmunity.

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia

Role of SOCS1 in tumor progression and therapeutic application.

SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control.

P2888

bcj.2017.67

P304

e588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BCJ.2017.67

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cheng-Hong Tsai

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090912158

http://www.w3.org/2001/XMLSchema#string

P698

28753595

http://www.w3.org/2001/XMLSchema#string

P932

5549259

http://www.w3.org/2001/XMLSchema#string